New therapy aims to ease anxiety and depression in LGBTQ+ community hit by pandemic

NCT ID NCT05540067

Ongoing Symptom relief Sponsor: Brown University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a short, acceptance-based therapy (ABBT) to help LGBTQ+ adults with mild anxiety or depression worsened by the COVID-19 pandemic. 240 participants will either receive the therapy or standard care. The goal is to see if ABBT can reduce symptoms and improve social support.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Acceptance-Based Behavior Therapy (ABBT)
What this could lead to: If it works, this could offer a short, practical therapy option to reduce anxiety and depression in LGBTQ+ individuals.
What could go wrong: This is a Phase 2 trial with 240 people, so results are still early. The therapy may not prove more effective than usual care, and benefits may not apply to all LGBTQ+ groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder COVID-19 Depression depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY DEPRESSION

Contacts and locations

Locations

Brown University

Providence, Rhode Island, 02912, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.